Leuthold Group LLC Sells 210 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Leuthold Group LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 19,710 shares of the company’s stock after selling 210 shares during the quarter. Leuthold Group LLC’s holdings in HCA Healthcare were worth $8,011,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of HCA. Canoe Financial LP bought a new position in shares of HCA Healthcare during the third quarter worth approximately $41,000. J.W. Cole Advisors Inc. increased its position in HCA Healthcare by 7.3% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 1,045 shares of the company’s stock worth $425,000 after buying an additional 71 shares during the period. State of Alaska Department of Revenue boosted its position in shares of HCA Healthcare by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 21,590 shares of the company’s stock valued at $8,774,000 after acquiring an additional 510 shares during the period. Carret Asset Management LLC raised its stake in HCA Healthcare by 7.2% in the 3rd quarter. Carret Asset Management LLC now owns 11,087 shares of the company’s stock worth $4,506,000 after purchasing an additional 742 shares in the last quarter. Finally, Financial Management Professionals Inc. raised its position in shares of HCA Healthcare by 54.5% in the third quarter. Financial Management Professionals Inc. now owns 238 shares of the company’s stock valued at $97,000 after buying an additional 84 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Barclays increased their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Oppenheimer raised their target price on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Finally, UBS Group raised their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $377.17.

HCA Healthcare Price Performance

Shares of HCA opened at $362.90 on Monday. The business’s 50 day moving average price is $395.06 and its two-hundred day moving average price is $352.71. The firm has a market cap of $95.05 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a 52-week low of $222.23 and a 52-week high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Activity

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.